Annual FCF
-$14.10 M
+$3.63 M+20.48%
December 31, 2023
Summary
- As of February 8, 2025, ENVB annual free cash flow is -$14.10 million, with the most recent change of +$3.63 million (+20.48%) on December 31, 2023.
- During the last 3 years, ENVB annual FCF has fallen by -$10.17 million (-258.50%).
- ENVB annual FCF is now -4248.16% below its all-time high of $339.90 thousand, reached on December 31, 2004.
Performance
ENVB Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$927.10 K
+$1.96 M+67.91%
September 30, 2024
Summary
- As of February 8, 2025, ENVB quarterly free cash flow is -$927.10 thousand, with the most recent change of +$1.96 million (+67.91%) on September 30, 2024.
- Over the past year, ENVB quarterly FCF has increased by +$1.96 million (+67.91%).
- ENVB quarterly FCF is now -184.95% below its all-time high of $1.09 million, reached on June 30, 2020.
Performance
ENVB Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$8.17 M
+$1.81 M+18.17%
September 30, 2024
Summary
- As of February 8, 2025, ENVB TTM free cash flow is -$8.17 million, with the most recent change of +$1.81 million (+18.17%) on September 30, 2024.
- Over the past year, ENVB TTM FCF has increased by +$1.81 million (+18.17%).
- ENVB TTM FCF is now -2131.75% below its all-time high of $401.90 thousand, reached on June 30, 2007.
Performance
ENVB TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
ENVB Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.5% | +67.9% | +18.2% |
| 3 y3 years | -258.5% | +73.3% | +54.0% |
| 5 y5 years | -449.6% | -100.0% | -258.0% |
ENVB Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -14.4% | +20.5% | at high | +82.0% | at high | +55.9% |
| 5 y | 5-year | -455.6% | +20.5% | -184.9% | +82.0% | -258.0% | +55.9% |
| alltime | all time | -4248.2% | +20.5% | -184.9% | +89.5% | -2131.8% | +55.9% |
Enveric Biosciences Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$927.10 K(-67.9%) | -$8.17 M(-18.2%) |
| Jun 2024 | - | -$2.89 M(+11.2%) | -$9.98 M(-13.6%) |
| Mar 2024 | - | -$2.60 M(+48.4%) | -$11.56 M(-18.0%) |
| Dec 2023 | -$14.10 M(-20.5%) | -$1.75 M(-36.1%) | -$14.10 M(-10.9%) |
| Sep 2023 | - | -$2.74 M(-38.6%) | -$15.82 M(-10.4%) |
| Jun 2023 | - | -$4.47 M(-13.2%) | -$17.65 M(-1.0%) |
| Mar 2023 | - | -$5.14 M(+48.3%) | -$17.82 M(+0.5%) |
| Dec 2022 | -$17.73 M(+43.9%) | -$3.47 M(-24.1%) | -$17.73 M(-4.3%) |
| Sep 2022 | - | -$4.57 M(-1.5%) | -$18.52 M(+14.6%) |
| Jun 2022 | - | -$4.64 M(-8.2%) | -$16.16 M(+19.3%) |
| Mar 2022 | - | -$5.05 M(+18.7%) | -$13.54 M(+9.9%) |
| Dec 2021 | -$12.32 M(+213.3%) | -$4.26 M(+93.0%) | -$12.32 M(+18.9%) |
| Sep 2021 | - | -$2.21 M(+9.1%) | -$10.36 M(+21.2%) |
| Jun 2021 | - | -$2.02 M(-47.3%) | -$8.55 M(+57.3%) |
| Mar 2021 | - | -$3.84 M(+67.3%) | -$5.43 M(+38.2%) |
| Dec 2020 | -$3.93 M(+55.0%) | -$2.29 M(+482.7%) | -$3.93 M(+47.1%) |
| Sep 2020 | - | -$393.70 K(-136.1%) | -$2.67 M(+17.3%) |
| Jun 2020 | - | $1.09 M(-146.7%) | -$2.28 M(-41.2%) |
| Mar 2020 | - | -$2.34 M(+125.6%) | -$3.88 M(+52.8%) |
| Dec 2019 | -$2.54 M(-1.1%) | -$1.04 M(<-9900.0%) | -$2.54 M(+1.8%) |
| Sep 2019 | - | $0.00(-100.0%) | -$2.49 M(-33.9%) |
| Jun 2019 | - | -$505.80 K(-49.2%) | -$3.77 M(+21.7%) |
| Mar 2019 | - | -$996.10 K(+0.5%) | -$3.10 M(+20.9%) |
| Dec 2018 | -$2.57 M(-6.6%) | -$991.40 K(-22.6%) | -$2.57 M(+2.1%) |
| Sep 2018 | - | -$1.28 M(-870.2%) | -$2.51 M(+88.9%) |
| Jun 2018 | - | $166.30 K(-136.2%) | -$1.33 M(-43.6%) |
| Mar 2018 | - | -$459.60 K(-51.0%) | -$2.36 M(-14.2%) |
| Dec 2017 | -$2.75 M(+0.5%) | -$938.30 K(+851.6%) | -$2.75 M(+78.0%) |
| Sep 2017 | - | -$98.60 K(-88.5%) | -$1.54 M(-62.8%) |
| Jun 2017 | - | -$860.40 K(+1.4%) | -$4.15 M(+15.1%) |
| Mar 2017 | - | -$848.40 K(-420.8%) | -$3.60 M(+31.8%) |
| Dec 2016 | -$2.73 M(-31.2%) | $264.50 K(-109.8%) | -$2.73 M(-8.8%) |
| Sep 2016 | - | -$2.70 M(+749.1%) | -$3.00 M(-67.3%) |
| Jun 2016 | - | -$318.10 K(-1572.7%) | -$9.16 M(-16.0%) |
| Mar 2016 | - | $21.60 K(-100.2%) | -$10.90 M(-0.2%) |
| Dec 2015 | -$3.97 M(+9097.7%) | - | - |
| Sep 2015 | - | -$8.86 M(+329.7%) | -$10.93 M(+429.0%) |
| Jun 2015 | - | -$2.06 M(>+9900.0%) | -$2.07 M(>+9900.0%) |
| Mar 2015 | - | -$1200.00(-70.0%) | -$16.60 K(-61.6%) |
| Dec 2014 | -$43.20 K(+100.0%) | -$4000.00(-407.7%) | -$43.20 K(+9.1%) |
| Sep 2014 | - | $1300.00(-110.2%) | -$39.60 K(-14.1%) |
| Jun 2014 | - | -$12.70 K(-54.3%) | -$46.10 K(+24.3%) |
| Mar 2014 | - | -$27.80 K(+6850.0%) | -$37.10 K(+72.6%) |
| Dec 2013 | -$21.60 K(-12.9%) | -$400.00(-92.3%) | -$21.50 K(-13.7%) |
| Sep 2013 | - | -$5200.00(+40.5%) | -$24.90 K(+0.4%) |
| Jun 2013 | - | -$3700.00(-69.7%) | -$24.80 K(-0.8%) |
| Mar 2013 | - | -$12.20 K(+221.1%) | -$25.00 K(+0.4%) |
| Dec 2012 | -$24.80 K(-18.2%) | -$3800.00(-25.5%) | -$24.90 K(-3.9%) |
| Sep 2012 | - | -$5100.00(+30.8%) | -$25.90 K(+5.7%) |
| Jun 2012 | - | -$3900.00(-67.8%) | -$24.50 K(-3.9%) |
| Mar 2012 | - | -$12.10 K(+152.1%) | -$25.50 K(-16.1%) |
| Dec 2011 | -$30.30 K(-25.6%) | -$4800.00(+29.7%) | -$30.40 K(+6.3%) |
| Sep 2011 | - | -$3700.00(-24.5%) | -$28.60 K(-55.2%) |
| Jun 2011 | - | -$4900.00(-71.2%) | -$63.80 K(+93.9%) |
| Mar 2011 | - | -$17.00 K(+466.7%) | -$32.90 K(-19.0%) |
| Dec 2010 | -$40.70 K | -$3000.00(-92.3%) | -$40.60 K(-11.0%) |
| Sep 2010 | - | -$38.90 K(-249.6%) | -$45.60 K(+342.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2010 | - | $26.00 K(-205.3%) | -$10.30 K(-82.5%) |
| Mar 2010 | - | -$24.70 K(+208.8%) | -$58.70 K(-9.7%) |
| Dec 2009 | -$65.00 K(-56.7%) | -$8000.00(+122.2%) | -$65.00 K(-25.5%) |
| Sep 2009 | - | -$3600.00(-83.9%) | -$87.20 K(-5.0%) |
| Jun 2009 | - | -$22.40 K(-27.7%) | -$91.80 K(-32.5%) |
| Mar 2009 | - | -$31.00 K(+2.6%) | -$135.90 K(-9.5%) |
| Dec 2008 | -$150.20 K(-145.5%) | -$30.20 K(+268.3%) | -$150.10 K(+9.5%) |
| Sep 2008 | - | -$8200.00(-87.7%) | -$137.10 K(-39.8%) |
| Jun 2008 | - | -$66.50 K(+47.1%) | -$227.70 K(+2.5%) |
| Mar 2008 | - | -$45.20 K(+162.8%) | -$222.20 K(-167.3%) |
| Dec 2007 | $329.90 K(-202.8%) | -$17.20 K(-82.6%) | $330.00 K(+3.9%) |
| Sep 2007 | - | -$98.80 K(+62.0%) | $317.70 K(-21.0%) |
| Jun 2007 | - | -$61.00 K(-112.0%) | $401.90 K(+7.5%) |
| Mar 2007 | - | $507.00 K(-1818.6%) | $374.00 K(-216.5%) |
| Dec 2006 | -$320.90 K(+22.6%) | -$29.50 K(+102.1%) | -$320.90 K(-17.0%) |
| Sep 2006 | - | -$14.60 K(-83.6%) | -$386.40 K(-2.4%) |
| Jun 2006 | - | -$88.90 K(-52.7%) | -$396.00 K(-17.3%) |
| Mar 2006 | - | -$187.90 K(+97.8%) | -$478.70 K(+82.8%) |
| Dec 2005 | -$261.80 K(-177.0%) | -$95.00 K(+292.6%) | -$261.80 K(+48.0%) |
| Sep 2005 | - | -$24.20 K(-85.9%) | -$176.90 K(-147.8%) |
| Jun 2005 | - | -$171.60 K(-691.7%) | $369.80 K(+28.0%) |
| Mar 2005 | - | $29.00 K(-387.1%) | $288.80 K(-15.0%) |
| Dec 2004 | $339.90 K(-232.9%) | -$10.10 K(-101.9%) | $339.80 K(+15.2%) |
| Sep 2004 | - | $522.50 K(-306.8%) | $294.90 K(-197.1%) |
| Jun 2004 | - | -$252.60 K(-415.8%) | -$303.60 K(+44.2%) |
| Mar 2004 | - | $80.00 K(-245.5%) | -$210.50 K(-17.6%) |
| Dec 2003 | -$255.70 K(-2631.7%) | -$55.00 K(-27.6%) | -$255.60 K(+1.1%) |
| Sep 2003 | - | -$76.00 K(-52.4%) | -$252.80 K(+19.2%) |
| Jun 2003 | - | -$159.50 K(-557.0%) | -$212.10 K(+492.5%) |
| Mar 2003 | - | $34.90 K(-166.9%) | -$35.80 K(-454.5%) |
| Dec 2002 | $10.10 K(-102.8%) | -$52.20 K(+47.9%) | $10.10 K(-93.4%) |
| Sep 2002 | - | -$35.30 K(-310.1%) | $151.90 K(+992.8%) |
| Jun 2002 | - | $16.80 K(-79.2%) | $13.90 K(-105.5%) |
| Mar 2002 | - | $80.80 K(-9.8%) | -$251.30 K(-30.2%) |
| Dec 2001 | -$360.00 K(-441.6%) | $89.60 K(-151.7%) | -$360.00 K(-14.4%) |
| Sep 2001 | - | -$173.30 K(-30.2%) | -$420.80 K(+71.3%) |
| Jun 2001 | - | -$248.40 K(+790.3%) | -$245.60 K(+29.5%) |
| Mar 2001 | - | -$27.90 K(-196.9%) | -$189.70 K(-280.2%) |
| Dec 2000 | $105.40 K(-115.3%) | $28.80 K(+1415.8%) | $105.30 K(+37.6%) |
| Sep 2000 | - | $1900.00(-101.0%) | $76.50 K(+2.5%) |
| Jun 2000 | - | -$192.50 K(-172.1%) | $74.60 K(-72.1%) |
| Mar 2000 | - | $267.10 K(+158.8%) | $267.10 K(-108.9%) |
| Dec 1999 | -$688.50 K(-77.6%) | - | - |
| Dec 1998 | -$3.07 M(-25.4%) | $103.20 K(-125.8%) | -$3.00 M(-33.7%) |
| Sep 1998 | - | -$400.00 K(-81.0%) | -$4.52 M(-2.2%) |
| Jun 1998 | - | -$2.10 M(+250.0%) | -$4.62 M(+27.6%) |
| Mar 1998 | - | -$600.00 K(-57.8%) | -$3.62 M(-12.1%) |
| Dec 1997 | -$4.12 M(-17.7%) | -$1.42 M(+184.4%) | -$4.12 M(-2.1%) |
| Sep 1997 | - | -$500.00 K(-54.5%) | -$4.21 M(-16.0%) |
| Jun 1997 | - | -$1.10 M(0.0%) | -$5.01 M(-3.8%) |
| Mar 1997 | - | -$1.10 M(-27.1%) | -$5.21 M(+4.0%) |
| Dec 1996 | -$5.01 M(+31.8%) | -$1.51 M(+16.0%) | -$5.01 M(+43.1%) |
| Sep 1996 | - | -$1.30 M(0.0%) | -$3.50 M(+59.1%) |
| Jun 1996 | - | -$1.30 M(+44.4%) | -$2.20 M(+144.4%) |
| Mar 1996 | - | -$900.00 K | -$900.00 K |
| Dec 1995 | -$3.80 M(+322.2%) | - | - |
| Dec 1994 | -$900.00 K(-57.1%) | - | - |
| Aug 1994 | -$2.10 M | - | - |
FAQ
- What is Enveric Biosciences annual free cash flow?
- What is the all time high annual FCF for Enveric Biosciences?
- What is Enveric Biosciences annual FCF year-on-year change?
- What is Enveric Biosciences quarterly free cash flow?
- What is the all time high quarterly FCF for Enveric Biosciences?
- What is Enveric Biosciences quarterly FCF year-on-year change?
- What is Enveric Biosciences TTM free cash flow?
- What is the all time high TTM FCF for Enveric Biosciences?
- What is Enveric Biosciences TTM FCF year-on-year change?
What is Enveric Biosciences annual free cash flow?
The current annual FCF of ENVB is -$14.10 M
What is the all time high annual FCF for Enveric Biosciences?
Enveric Biosciences all-time high annual free cash flow is $339.90 K
What is Enveric Biosciences annual FCF year-on-year change?
Over the past year, ENVB annual free cash flow has changed by +$3.63 M (+20.48%)
What is Enveric Biosciences quarterly free cash flow?
The current quarterly FCF of ENVB is -$927.10 K
What is the all time high quarterly FCF for Enveric Biosciences?
Enveric Biosciences all-time high quarterly free cash flow is $1.09 M
What is Enveric Biosciences quarterly FCF year-on-year change?
Over the past year, ENVB quarterly free cash flow has changed by +$1.96 M (+67.91%)
What is Enveric Biosciences TTM free cash flow?
The current TTM FCF of ENVB is -$8.17 M
What is the all time high TTM FCF for Enveric Biosciences?
Enveric Biosciences all-time high TTM free cash flow is $401.90 K
What is Enveric Biosciences TTM FCF year-on-year change?
Over the past year, ENVB TTM free cash flow has changed by +$1.81 M (+18.17%)